Contingency Management and Pre-Exposure Prophylaxis Adherence Support Services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs is a research paper published in Contemporary Clinical Trials (2022). On theSindex it has a DataRank of 0.514. It has been cited 11 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.141
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Institute on Drug Abuse
Grant: R01DA051871
NCATS NIH HHS
Grant: UL1 TR001863
NIDA NIH HHS
Grant: P30 DA040500
National Institutes of Health
Grant: 5R01DA051871-04
Promoting HIV risk reduction among people who inject drugs: A stepped care approach using contingency management with PrEP navigation
National Institutes of Health
Grant: 3UL1TR001863-08S1
Yale Clinical and Translational Science Award: Nwanaji-Enwerem Diversity in Health Related Research
U.S. Department of Veterans Affairs
Health Services Research and Development
National Institutes of Health
FWCI
0.97
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals